Navigation Links
Morgan & Morgan's Personal Injury Attorneys Provide Information About Yaz, Yasmin, and Ocella Injuries and Potential Health Risks
Date:2/24/2010

Popular birth control pills Yaz, Yasmin, and Ocella linked to potentially serious health risks. The injury lawyers at Morgan & Morgan are alerting consumers of these side effects and reviewing possible lawsuits.

(PRWEB) February 24, 2010 -- The attorneys at Morgan & Morgan, PA are currently evaluating potential legal claims for users of the birth control pills Yaz, Yasmin, and Ocella who have suffered serious side effects or injury. Yaz, Yasmin, and Ocella are once a day oral contraceptives that have been linked to dangerous health problems, including heart attacks, strokes, gallbladder problems, and blood clots.

Yasmin and Yaz are two separate but related birth control pills manufactured by Bayer Healthcare. Ocella is the generic version of Yasmin. These oral contraceptives, which are taken to prevent unwanted pregnancies, contain a different kind of hormone called drsp, or drospirenone. Drospirenone can cause increased potassium levels in some women, which can lead to health problems. People with kidney, liver, or adrenal disease are at an increased risk for developing negative Yaz side effects from using these birth control drugs.

Several Yaz lawsuits were filed in the summer of 2009, alleging that Bayer overstated the benefits of Yaz while failing to warn women that it could put them at risk for potentially life threatening injuries. It is expected that similar Yaz and Yasmin lawsuits will be filed in the future. Women may be entitled to financial compensation if they have suffered any of the following side effects: heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), gallbladder disease, or blood clot.

If you or a loved one has suffered serious medical problems after taking Yaz, Yasmin, or Ocella, you may have valuable legal rights. Visit ForThePeople.com and fill out the Free Case Evaluation form to find out if you are eligible to participate in a Yaz lawsuit. Morgan & Morgan’s Yaz and Yasmin lawyers are experienced in litigating dangerous and defective drug cases and have the resources and knowledge to pursue justice on your behalf.

About Morgan & Morgan

Morgan & Morgan is one of the largest Personal Injury law firms in the country with offices nationwide. The firm handles product liability cases, personal injury cases, and medical malpractice cases, as well as claims against drug and medical device manufacturers. Visit ForThePeople.com for a free case evaluation and information about your legal rights.

###

Read the full story at http://www.prweb.com/releases/florida-injury-lawyers/yaz-yasmin-injuries/prweb3642574.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Virginia House Majority Leader Morgan Griffith Sponsors Legislation Enabling Mobile Solution for Health Care SALEM, Va.
2. BMEGateway Celebrates its 20th Anniversary and Welcomes Dr. William Morgan
3. Emdeon to Present at the 28th Annual J.P. Morgan Healthcare Conference
4. Mindray Medical to Present at the 28th Annual J.P. Morgan Healthcare Conference and Jefferies 2010 Global Healthcare Services Conference
5. Triple-S Management Corporation to Present at J. P. Morgan Healthcare Conference
6. HealthSouth to Present at J.P. Morgan Healthcare Conference
7. Savient To Present at the 28th Annual JP Morgan Healthcare Conference
8. St. Andrews Country Club Announces Dates and Players for Third Annual Morgan & Friends Fight Cancer Tournament
9. Henry Schein to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Morgan & Morgan's Personal Injury Attorneys Provide Information About Yaz, Yasmin, and Ocella Injuries and Potential Health Risks 
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
Breaking Medicine Technology: